Many Mednax, Inc(MD) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. MEDNAX Inc was Downgraded by Jefferies to Hold on Dec 13, 2016. MEDNAX Inc was Initiated by Goldman to Neutral on Dec 9, 2016.
Company has reported several Insider transactions to the SEC, on Feb 13, 2017, Md Pascal J Goldschmidt, (director) sold 25,294 shares at 67.82 per share price.On Feb 10, 2017, Md Carlo A Waldemar, (director) sold 5,334 shares at 67.90 per share price.On Jan 17, 2017, Vivian Lopez-blanco (Chief Financial Officer) sold 10,000 shares at 70.95 per share price.
MEDNAX Inc Last issued its quarterly earnings results on Feb 7, 2017. The company reported $1.00 EPS for the quarter, missing the analyst consensus estimate by $ -0.06. Analyst had a consensus of $1.06. The company had revenue of $830.80 million for the quarter, compared to analysts expectations of $842.26 million. The companys revenue was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.13 EPS.
Mednax, Inc (NYSE:MD) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2.33 by 12 Brokerage Firm. 4 Wall Street Firms have rated the stock as a strong buys. 8 Brokerage Firms have advised hold.
Mednax, Inc (NYSE:MD): The mean short term price target for Mednax, Inc (NYSE:MD) has been established at $68.5 per share. The higher price target estimate is at $77 and the lower price target estimate is expected at $63 according to 8 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $4.63
Mednax, Inc (NYSE:MD) rose 0.68% or 0.46 points on Tuesday and made its way into the gainers of the day. After trading began at $67.92 the stock was seen hitting $68.85 as a peak level and $67.87 as the lowest level. The stock ended up at $68.56. The daily volume was measured at 1,307,694 shares. The 52-week high of the share price is $76.96 and the 52-week low is $59.36. The company has a market cap of $6,430 million.
Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives.